Abstract
Boron-containing analogues of ether lipids are proposed as boron carriers in the boron neutron capture therapy (BNCT). The synthesis of rac-1-(9-o-Carboranyl)nonyl-2-methyl-glycero- 3-phosphocholine (B-Et-11-OMe) as a first representative is described. The carborane is introduced into the readily assembled glycerol ether moiety. The phosphocholine headgroup is introduced by 2-chloro-3-methyl-1,3,2-λ3-oxazaphospholane using a phosphoamidite strategy and subsequent ring opening under alkylating conditions.
| Original language | English |
|---|---|
| Pages (from-to) | 185-191 |
| Number of pages | 7 |
| Journal | Chemistry and Physics of Lipids |
| Volume | 62 |
| Issue number | 2 |
| DOIs | |
| State | Published - Sep 1992 |
Keywords
- BNCT
- boron neutron capture therapy
- ether lipid
- glycidyl ether
- phosphoamidite
Fingerprint
Dive into the research topics of 'Synthesis of rac-1-(9-o-carboranyl)nonyl-2-methyl-glycero-3-phosphocholine (B-Et-11-OMe), a potential boron carrier for Boron Neutron Capture Therapy (BNCT)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver